Abstract
Fragment-based drug discovery (FBDD) needs a biophysical assay to complement, or even replace, biochemical screening. NMR is the best choice for this because NMR delivers many different types of data that impacts medicinal chemistry decisions. There are a multitude of different NMR methods which can be employed to these ends. The choice of which method to use will be different for every need. We discuss the different methods, the data they produce, and how they are best utilized in a FBDD setting.
Keywords: NMR, Fragment, Screening, protein-based, ligand-based
Current Topics in Medicinal Chemistry
Title: Practical Aspects of NMR-based Fragment Discovery
Volume: 7 Issue: 16
Author(s): Edward R. Zartler and Huaping Mo
Affiliation:
Keywords: NMR, Fragment, Screening, protein-based, ligand-based
Abstract: Fragment-based drug discovery (FBDD) needs a biophysical assay to complement, or even replace, biochemical screening. NMR is the best choice for this because NMR delivers many different types of data that impacts medicinal chemistry decisions. There are a multitude of different NMR methods which can be employed to these ends. The choice of which method to use will be different for every need. We discuss the different methods, the data they produce, and how they are best utilized in a FBDD setting.
Export Options
About this article
Cite this article as:
Zartler R. Edward and Mo Huaping, Practical Aspects of NMR-based Fragment Discovery, Current Topics in Medicinal Chemistry 2007; 7 (16) . https://dx.doi.org/10.2174/156802607782341055
DOI https://dx.doi.org/10.2174/156802607782341055 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bipolar Depression: The Neglected Realm of Postpartum Disorders
Current Psychiatry Reviews Functional Interactions of Tau and their Relevance for Alzheimers Disease
Current Alzheimer Research Transitional Polytherapy: Tricks of the Trade for Monotherapy to Monotherapy AED Conversions
Current Neuropharmacology Improvement of Learning and Increase in Dopamine Level in the Frontal Cortex by Methylphenidate in Mice Lacking Dopamine Transporter
Current Molecular Medicine Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Sublethal Total Body Irradiation Leads to Early Cerebellar Damage and Oxidative Stress
Current Neurovascular Research Prevalence of the Use of Opioids for Treatment of Pain in Persons with a Cognitive Impairment Compared with Cognitively Intact Persons: A Systematic Review
Current Alzheimer Research The Role of miR-124 in Drosophila Alzheimer's Disease Model by Targeting Delta in Notch Signaling Pathway
Current Molecular Medicine Cardiovascular and Renovascular Implications of COX-2 Inhibition
Current Pharmaceutical Design Orphan GPCR Ligands Related to Obesity
Current Medicinal Chemistry - Central Nervous System Agents Current Study on the Development of Bis-pyridinium Oxime Reactivators for the Antidotal Treatment of Poisoning by Toxic Organophosphorus Agents
Current Organic Chemistry Meet Our Editorial Board Member:
Current Protein & Peptide Science Professionalism and Adolescent Psychiatry in the Digital Age
Adolescent Psychiatry BDNF/NF-κB Signaling in the Neurobiology of Depression
Current Pharmaceutical Design The Use of Stem Cells in Regenerative Medicine for Parkinson’s and Huntington’s Diseases
Current Medicinal Chemistry The Risk That DSM-5 Will Further Inflate the Diagnostic Bubble
Current Psychiatry Reviews Alzheimer's Disease-Like Pathologies and Cognitive Impairments Induced by Formaldehyde in Non-Human Primates
Current Alzheimer Research Mice in Ecstasy: Advanced Animal Models in the Study of MDMA
Current Pharmaceutical Biotechnology Editorial [Disparity in Pharmacotherapies]
Current Drug Therapy Natural Compounds and Plant Extracts as Therapeutics Against Chronic Inflammation in Alzheimer's Disease - A Translational Perspective
CNS & Neurological Disorders - Drug Targets